Table of Contents Author Guidelines Submit a Manuscript
Volume 6, Pages 1770-1782
Review Article

Peroxisome Proliferator-Activated Receptors and Shock State

1Department of Experimental Pharmacology, University of Naples “Federico II”, Naples, Italy
2IRCCS Centro Neurolesi “Bonino-Pulejo”, Messina, Italy
3Department of Clinical and Experimental Medicine and Pharmacology, Torre Biologica Policlinico Universitario, Messina, Italy

Received 26 October 2006; Revised 13 December 2006; Accepted 13 December 2006

Copyright © 2006 Emanuela Esposito et al.

Citations to this Article [7 citations]

The following is the list of published articles that have cited the current article.

  • María Isabel Panadero, María del Carmen González, Emilio Herrera, and Carlos Bocos, “Modulación del PPARα por agentes farmacológicos y naturales y sus implicaciones metabólicas,” Clínica e Investigación en Arteriosclerosis, vol. 20, no. 6, pp. 259–289, 2008. View at Publisher · View at Google Scholar
  • Nagapradeep Nagajothi, Sasikanth Adigopula, Saravanan Balamuthusamy, Jose-Luis E. Velazquez-Cecena, Kalpana Raghunathan, Ahmad Khraisat, Sarabjeet Singh, Janos Molnar, Sandeep Khosla, and Daniel Benatar, “Pioglitazone and the risk of myocardial infarction and other major adverse cardiac events: A meta-analysis of randomized, controlled trials,” American Journal of Therapeutics, vol. 15, no. 6, pp. 506–511, 2008. View at Publisher · View at Google Scholar
  • Irene Paterniti, Emanuela Esposito, Emanuela Mazzon, Maria Galuppo, Rosanna Di Paola, Placido Bramanti, Amar Kapoor, Christoph Thiemermann, and Salvatore Cuzzocrea, “Evidence for the Role of Peroxisome Proliferator-Activated Receptor-beta/delta in the Development of Spinal Cord Injury,” Journal Of Pharmacology And Experimental Therapeutics, vol. 333, no. 2, pp. 465–477, 2010. View at Publisher · View at Google Scholar
  • Rosanna Di Paola, Concetta Crisafulli, Emanuela Mazzon, Emanuela Esposito, Irene Paterniti, Maria Galuppo, Tiziana Genovese, Christoph Thiemermann, and Salvatore Cuzzocrea, “GW0742, A HIGH-AFFINITY PPAR -β/δ AGONIST, INHIBITS ACUTE LUNG INJURY IN MICE,” Shock, vol. 33, no. 4, pp. 426–435, 2010. View at Publisher · View at Google Scholar
  • Cheng-Chia Tsai, Kung-Shing Lee, Sheng-Hsien Chen, Li-Jen Chen, Keng-Fan Liu, and Juei-Tang Cheng, “Decrease of PPAR in Type-1-Like Diabetic Rat for Higher Mortality after Spinal Cord Injury,” PPAR Research, vol. 2014, pp. 1–7, 2014. View at Publisher · View at Google Scholar
  • Chien-Min Lin, Jo-Ting Tsai, Chen Kuei Chang, Juei-Tang Cheng, and Jia-Wei Lin, “Development of telmisartan in the therapy of spinal cord injury: pre-clinical study in rats,” Drug Design Development And Therapy, vol. 9, pp. 4709–4717, 2015. View at Publisher · View at Google Scholar
  • Zivar Yousefipour, Neha Chug, Katarzyna Marek, Alicia Nesbary, Joseph Mathew, Kasturi Ranganna, and Mohammad A. Newaz, “ Contribution of PPARγ in modulation of acrolein-induced inflammatory signaling in gp91 phox knock-out mice ,” Biochemistry and Cell Biology, pp. 1–9, 2017. View at Publisher · View at Google Scholar